MINI FUTURE OPTIONSSCHEIN PUT - BIOGEN IDEC | Delayed Deutsche Boerse AG 12:04:49 2024-06-17 pm EDT | ||
| 5.85 EUR | +6.75% |
|
| Current month | -10.02% | ||
| 1 month | -7.12% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-17 | 5.85 | +6.75% |
| 24-06-14 | 5.48 | +3.40% |
| 24-06-13 | 5.3 | -6.53% |
| 24-06-12 | 5.67 | -4.55% |
| 24-06-11 | 5.94 | -0.50% |
Delayed Quote Deutsche Boerse AG
Last update June 17, 2024 at 12:04 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ4YZ1 |
| ISIN | DE000DJ4YZ15 |
| Date issued | 2023-08-18 |
| Strike | 288.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.38 € |
|---|---|
| Lowest since issue | 1.52 € |
| Spread | 0.01 € |
| Spread % | 0.17% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
231.7
USD
Average target price
284.6
USD
Spread / Average Target
+22.85%
- Stock Market
- Certificates
- Certificat
